期刊文献+

红斑狼疮患者外周血内皮祖细胞数量与颈动脉内膜-中膜厚度相关性研究

The correlation between peripheral endothelial progenitor cells levels and the intima-mediathickness of carotid artery in patients with systemic lupus erythematosus
下载PDF
导出
摘要 目的探讨系统性红斑狼疮(SLE)患者外周血内皮祖细胞(EPC)与颈动脉内膜-中膜厚度(IMT)的关系。方法连续选入40例SLE患者做为SLE组,超声检测颈动脉IMT按IMT增厚与否分为IMT正常组和IMT增厚组,20名门诊健康体检者为对照组。流式细胞分析计量外周血EPC(CD34和KDR双阳性细胞);比较各组EPC数量及直线相关分析EPC数量和IMT相关性。结果SLE组外周血EPC数量较对照组显著减少,P<0.01;同时在SLE组中IMT增厚组EPC数量低于IMT正常组,P<0.01,且IMT与外周血EPC数量呈负相关(n=40,r=-0.494,P=0.006)。结论SLE患者存在早期动脉粥样硬化,外周血EPC数量降低与颈动脉IMT增加密切相关,外周血EPC数量降低可能是SLE引起早期动脉粥样硬化的重要原因之一。 Objective To investigate the correlation between peripheral endothelial progenitor cells(EPC) levels and the intima-media thickness(IMT) of carotid artery in patients with systemic lupus erythematosus(SLE).Methods Peripheral EPC was enumerated as CD34+/KDR+cell via fluorescence-activated cell sorter analysis,and the IMT of carotid artery was measured,respectively in 40 SLE patients and 20 controls.The patients with SLE were divided into two subgroups according to IMT≥1.0 mm and IMT〈1.0 mm.Results The number of EPC was decreased in SLE,P0.01.In addition,The number of EPC in the IMT≥1.0 mm subgroup was observed lower than that in the IMT〈1.0 mm subgroup,P0.01,the number of EPC was negatively related to the IMT in patients with SLE(r=-0.494,P=0.006).Conclusions Premature atherosclerosis exists in SLE patients,there is a correlation between peripheral EPC level and the IMT of carotid artery.The decrease of EPC may be an important factor of the SLE induced atherosclerosis.
机构地区 解放军第
出处 《局解手术学杂志》 2010年第2期123-124,共2页 Journal of Regional Anatomy and Operative Surgery
关键词 系统性红斑狼疮 内皮祖细胞 颈动脉内、中膜厚度 systemic lupus erythematosus endothelial progenitor cells intima-media thickness
  • 相关文献

参考文献6

二级参考文献22

  • 1孙公平,朱新旺,王亚杰.同型半胱氨酸与动脉粥样硬化性血管病[J].中国心血管杂志,2006,11(1):68-70. 被引量:15
  • 2成君,赵冬,王薇,李治安,勇强,孙佳艺,赵丽雅,吴兆苏.心血管病危险因素与10年后颈动脉粥样硬化的关系[J].中华内科杂志,2006,45(3):206-209. 被引量:47
  • 3Liang MH, Mahdl LA, Costenbader K, et al. Atherosclerotic vascular disease in systemic lupus erythematosus. J Natl Med Assoc, 2002,94:813-819.
  • 4Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus: quantification olr degrees olr narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med ,1981,70 : 775-781.
  • 5Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy.Am J Med , 1975,58:243-264.
  • 6MacGregor AJ, Dhillon VB, Binder A, et al. Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. Ann Rheum Dis,1992,51:152-155.
  • 7Romero FI, Atsumi T, Tinahones FJ, et al. Autoantibodies against malondialdehyde-modified lipoprotein (a) in antiphospholipid syndrome. Arthritis Rheum, 1999,42:2606-2611.
  • 8Landewe RB, van den Borne BE, Breedveld FC, et al.Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet ,2000,355:1616-1617.
  • 9Rahman P, Urowitz MB, Gladman DD, et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol, 1999, 26: 2363-2368.
  • 10Ura M, Sakata R, Nakayama Y, et al. Coronary artery bypass grafting in patients with systemic lupus erythematosus. Eur J Cardiothorae Surg , 1999,15:697-701.

共引文献203

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部